Fentanyl Citrate 25 µg/0.1 mL Nasal Spray is a potent opioid analgesic designed for rapid absorption through the nasal mucosa. By delivering the medication directly into the nasal cavity, it allows for swift onset of pain relief, making it particularly useful for managing acute episodes of pain where immediate analgesia is desired.

The nasal spray formulation offers a non-invasive and convenient route of administration, bypassing the gastrointestinal tract and first-pass metabolism in the liver. This enhances bioavailability and ensures that a consistent dose reaches systemic circulation promptly. It's especially beneficial for patients who may have difficulty swallowing oral medications or require rapid pain control.

Due to its strength and potential risks, Fentanyl Citrate Nasal Spray should be used under strict medical supervision. It's essential for prescribers to assess each patient's opioid tolerance and overall health status to determine the appropriate dosing regimen. The medication is typically reserved for individuals who are already opioid-tolerant to minimize the risk of severe respiratory depression and other adverse effects.

Patients using this nasal spray should be thoroughly educated on its proper use to ensure accurate dosing and to mitigate potential side effects. Common side effects may include drowsiness, dizziness, nausea, constipation, and nasal irritation. It's crucial for patients to report any signs of adverse reactions or concerns promptly to their healthcare provider.

For prescribers, it's important to consider the patient's entire medication profile to avoid dangerous drug interactions. Concomitant use of other central nervous system depressants, such as benzodiazepines or alcohol, can amplify the effects of fentanyl, leading to heightened risks. Regular monitoring and patient counseling can help in managing these risks effectively.

If you have any questions, please reach out to us.

Fentanyl Citrate 25 µg/0.1 mL Nasal Spray is a potent opioid analgesic used for the management of breakthrough pain in patients who are already receiving and are tolerant to opioid therapy for their underlying persistent pain. As with any medication, it is crucial to be aware of potential drug interactions that may affect the efficacy and safety of this formulation.

Concomitant use of Fentanyl Citrate Nasal Spray with other central nervous system (CNS) depressants, including other opioids, sedatives, hypnotics, general anesthetics, phenothiazines, tranquilizers, muscle relaxants, and alcohol, can result in profound sedation, respiratory depression, coma, or even death. It is essential for prescribers to evaluate the patient's medication regimen and adjust dosages accordingly to minimize these risks.

Fentanyl is primarily metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme. Therefore, the use of Fentanyl Citrate Nasal Spray with CYP3A4 inhibitors, such as certain antibiotics (e.g., erythromycin), antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), can lead to increased plasma concentrations of fentanyl, potentially resulting in increased or prolonged opioid effects. Patients should be monitored for signs of respiratory and CNS depression, and dosage adjustments may be necessary.

Conversely, CYP3A4 inducers, such as rifampin, carbamazepine, and phenytoin, may decrease fentanyl plasma concentrations, reducing its efficacy. Patients may require an increased dose of Fentanyl Citrate Nasal Spray to achieve the desired analgesic effect, but this should be approached with caution to avoid overdose if the inducer is discontinued.

Monoamine oxidase inhibitors (MAOIs) can interact with opioid analgesics, including fentanyl, and may cause serotonin syndrome, a potentially life-threatening condition. It is generally advised to avoid the use of Fentanyl Citrate Nasal Spray in patients who are currently taking MAOIs or have taken them within the last 14 days.

Patients with a history of substance abuse or addiction should be closely monitored, as fentanyl has a high potential for abuse and dependence. Prescribers should assess the patient's risk for opioid addiction, abuse, or misuse prior to prescribing Fentanyl Citrate Nasal Spray and continue to monitor for the development of these behaviors or conditions.

It is important for both patients and prescribers to be aware of these potential drug interactions and to communicate openly about all medications being taken, including over-the-counter drugs and supplements. If you have any questions or concerns regarding the use of Fentanyl Citrate 25 µg/0.1 mL Nasal Spray and its interactions with other medications, please reach out to us for further guidance and support.

Fentanyl Citrate 25 µg/0.1 mL Nasal Spray is a specialized liquid formulation designed for intranasal administration, allowing for rapid absorption through the nasal mucosa. This method of delivery is particularly advantageous due to the rich vascularization of the nasal cavity, which facilitates swift entry of the medication into the systemic circulation. The nasal spray form ensures that the medication bypasses the gastrointestinal tract and first-pass metabolism in the liver, leading to a quicker onset of action compared to oral formulations. This is especially beneficial for managing acute pain episodes where rapid relief is essential.

Fentanyl, a potent synthetic opioid, works primarily by binding to the body's opioid receptors, which are found in the brain, spinal cord, and other areas. These receptors are part of the endogenous pain control system and, when activated by fentanyl, they inhibit the transmission of pain signals, alter the perception of pain, and increase pain tolerance. The citrate form of fentanyl enhances its solubility, making it suitable for nasal spray formulations, ensuring that the drug is effectively absorbed through the nasal tissues.

This formulation is particularly useful in treating breakthrough pain in patients who are already receiving and are tolerant to opioid therapy for underlying chronic pain conditions. Breakthrough pain is a sudden and intense flare-up of pain that "breaks through" the regular pain medication regimen. The rapid absorption and onset of action of the nasal spray make it an ideal choice for such situations, providing quick relief and improving the patient's quality of life.

For prescribers, it is important to consider the patient's overall opioid tolerance and history before prescribing this formulation. The dosing should be carefully tailored to the individual, taking into account their current opioid regimen to avoid the risk of overdose and potential side effects such as respiratory depression. Patients should be educated on the proper use of the nasal spray, including priming the spray pump if necessary, and ensuring the correct administration technique to maximize efficacy and minimize wastage.

Patients should be advised to use the nasal spray only as directed by their healthcare provider and to report any adverse effects or concerns promptly. It is crucial to store the medication safely to prevent misuse or accidental exposure, especially in households with children or individuals who may be at risk of opioid misuse.

If you have any questions or need further information about Fentanyl Citrate 25 µg/0.1 mL Nasal Spray, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation.

Fentanyl Citrate 25 µg/0.1 mL Nasal Spray is primarily used for managing breakthrough pain in patients who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain. However, this formulation may have other potential uses that could be considered by healthcare providers. One such use is in the management of severe, acute pain episodes in non-cancer patients who have developed opioid tolerance due to chronic pain conditions. This could include patients with severe arthritis, neuropathic pain, or other chronic pain syndromes where rapid pain relief is necessary and traditional oral or transdermal routes are not suitable or effective.

Additionally, the nasal spray formulation offers a non-invasive and rapid onset of action, which can be particularly beneficial in emergency settings or for patients who have difficulty swallowing or require immediate pain relief. This could extend its use to situations such as acute post-operative pain management, where quick pain control is essential, and the patient is already opioid-tolerant. Furthermore, the nasal route of administration bypasses the gastrointestinal tract, making it a viable option for patients with gastrointestinal issues that may impair drug absorption or for those experiencing nausea and vomiting.

For prescribers, it is crucial to assess the patient's opioid tolerance and overall health status before considering this formulation for off-label uses. The potential for misuse, abuse, and addiction should be carefully evaluated, and patients should be monitored closely for any adverse effects or signs of opioid toxicity. Patients should be educated on the proper use of the nasal spray, including the importance of adhering to prescribed dosages and the risks associated with deviation from the prescribed regimen.

As with any medication, the decision to use Fentanyl Citrate Nasal Spray for indications other than its primary approved use should be based on a thorough risk-benefit analysis and in consultation with a healthcare professional. If you have any questions or need further information, please reach out to us at Bayview Pharmacy. We are here to assist both patients and prescribers in making informed decisions regarding the use of compounded medications.